44.66
Bruker Corp stock is traded at $44.66, with a volume of 1.54M.
It is up +0.56% in the last 24 hours and up +4.69% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
See More
Previous Close:
$44.41
Open:
$44.97
24h Volume:
1.54M
Relative Volume:
0.52
Market Cap:
$6.79B
Revenue:
$3.44B
Net Income/Loss:
$75.20M
P/E Ratio:
85.25
EPS:
0.5239
Net Cash Flow:
$49.30M
1W Performance:
-3.69%
1M Performance:
+4.69%
6M Performance:
+16.21%
1Y Performance:
-19.36%
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BRKR
Bruker Corp
|
44.66 | 6.75B | 3.44B | 75.20M | 49.30M | 0.5239 |
|
ABT
Abbott Laboratories
|
125.12 | 220.33B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.11 | 140.06B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.11 | 134.83B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.48 | 126.02B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.80 | 49.23B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-09-25 | Initiated | Goldman | Sell |
| Nov-20-25 | Initiated | Rothschild & Co Redburn | Buy |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
AbCellera stock jumps after settlement with Bruker in patent dispute - Investing.com
Bruker (BRKR) Agrees to $36M Settlement with AbCellera (ABCL) - GuruFocus
AbCellera settles patent litigation with Bruker over microfluidic device tech - Seeking Alpha
AbCellera settles patent dispute with Bruker for $36 million upfront - Investing.com
AbCellera and Bruker Reach Global Settlement of Patent Litigation - Yahoo Finance
How Recent Analyst Shifts Are Reshaping The Bruker Investment Story - Yahoo Finance
YieldBoost Bruker From 0.4% To 11.2% Using Options - Nasdaq
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $55 to $60 - 富途牛牛
Bruker Corporation $BRKR Shares Sold by Squarepoint Ops LLC - MarketBeat
Wells Fargo Raises Bruker (BRKR) Price Target to $55 | BRKR Stoc - GuruFocus
Wells Fargo Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $55 - 富途牛牛
Bank of America Raises Bruker (NASDAQ:BRKR) Price Target to $60.00 - MarketBeat
Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $55 - 富途牛牛
Does Bruker (NASDAQ:BRKR) Have A Healthy Balance Sheet? - 富途牛牛
Goldman Sachs Initiates Sell Rating On Bruker Corporation (BRKR) - Insider Monkey
Stocks making big moves this week: Monolithic Power Systems, Alphabet, Enova, Revolve, and Bruker - Yahoo Finance
Becker Capital Management Inc. Takes $1.76 Million Position in Bruker Corporation $BRKR - MarketBeat
Bruker secures $10M in federally funded NMR orders from NYSBC, Delaware, and Northwestern - MSN
BBH Select Series – Mid Cap Fund Sold Bruker Corporation (BRKR) Due to Policy Uncertainty - Insider Monkey
Bank of Nova Scotia Grows Stock Holdings in Bruker Corporation $BRKR - MarketBeat
EDENTREE ASSET MANAGEMENT Ltd Buys 103,500 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
Wolfe Research Upgrades Bruker Corp(BRKR.US) to Buy Rating, Announces Target Price $60 - 富途牛牛
Why Bruker (BRKR) Stock Is Up Today - Finviz
Bruker stock steady as Leerink Partners reiterates Outperform rating By Investing.com - Investing.com Canada
Bruker stock steady as Leerink Partners reiterates Outperform rating - Investing.com
Bruker raised to outperform at Wolfe on 2026 outlook - MSN
Bruker Announces Orders for High-Performance Magnetic Resonance - GuruFocus
Bruker secures $25 million in European magnetic resonance orders By Investing.com - Investing.com Canada
Wolfe Research upgrades Bruker stock rating to Outperform with $60 target - Investing.com Canada
Bruker secures $25 million in European magnetic resonance orders - Investing.com
Bruker Announces Orders for High-Performance Magnetic Resonance Systems for Materials and Life-Science Research from Leading European Institutions – Company Announcement - Financial Times
First Trust Advisors LP Acquires 257,755 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker (BRKR): Buy, Sell, or Hold Post Q3 Earnings? - Barchart.com
Goldman Sachs Initiates Coverage of Bruker CorporationPreferred Stock (BRKRP) with Sell Recommendation - Nasdaq
Goldman Sachs initiates Bruker stock with Sell rating on weak growth outlook - Investing.com Canada
Bruker appoints diagnostics veteran Jack Phillips to board - Investing.com
Bruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026 - marketscreener.com
Bruker Corporation $BRKR Shares Sold by Quantbot Technologies LP - MarketBeat
Reassessing Bruker (BRKR) Valuation After Earnings Beat but Full-Year Outlook Cut - simplywall.st
Assessing Bruker After a 19.8% Rebound and Mixed Valuation Signals - Yahoo Finance
Taking Stock of Bruker (BRKR): Valuation After an Earnings Beat and Full-Year Guidance Cut - Yahoo Finance
QSV Equity Investors LLC Acquires New Position in Bruker Corporation $BRKR - MarketBeat
Bruker’s Q3 Beat And Guidance Cut Might Change The Case For Investing In Bruker (BRKR) - Yahoo Finance
Ex-Dividend Reminder: Ralliant, Alphabet and Bruker - Nasdaq
How Bruker Corporation stock performs during Fed tightening cyclesMarket Sentiment Report & High Accuracy Swing Trade Signals - Newser
Why Bruker Corporation stock could be next big winnerEarnings Performance Report & Accurate Buy Signal Notifications - Newser
How Investors May Respond To Bruker (BRKR) Beating Q3 EPS While Cutting 2025 Outlook - simplywall.st
Bruker (BRKR) Up 17.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
JPMorgan Chase & Co. Has $33.35 Million Stock Holdings in Bruker Corporation $BRKR - MarketBeat
OMERS ADMINISTRATION Corp Purchases 28,000 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):